Molecular study of WISP3 in nine families originating from the Middle-East and presenting with progressive pseudorheumatoid dysplasia:: Identification of two novel mutations, and description of a founder effect

被引:40
作者
Delague, V
Chouery, E
Corbani, S
Ghanem, I
Aamar, S
Fischer, J
Levy-Lahad, E
Urtizberea, JA
Mégarbané, A
机构
[1] St Josephs Univ, Fac Med, Unite Genet Med, Lab Biol Mol & Cytogenet, F-75007 Paris, France
[2] Fac Med Timone, INSERM, U491, Marseille, France
[3] Hop Hotel Dieu, Serv Orthopedie, Beirut, Lebanon
[4] Hadassah Univ Hosp, Rheumatol Clin, Mt Scopus, Israel
[5] Ctr Natl Genotype, Evry, France
[6] Shaare Zedek Med Ctr, Med Genet Unit, Jerusalem, Israel
[7] Hop La Pitie Salpetriere, Inst Myol, Paris, France
关键词
pseudorheumatoid progressive dysplasia; WISP3; platyspondyly; wide metaphyses; founder effect;
D O I
10.1002/ajmg.a.30906
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Progressive pseudorheumatoid dysplasia (PPD) is a rare autosomal recessive syndrome characterized by the presence of spondyloepiphyseal dysplasia associated with pain, stiffness, and swelling of multiple joints, osteoporosis, and the absence of destructive bone changes. The disorder is caused by mutations of the WISP3 gene located on chromosome 6q22. We hereby report the molecular study of the WISP3 gene in nine unrelated consanguineous families originating from the Middle-East: three from Lebanon, five from Syria, and one from Palestinian Bedouin descent, all affected with PPD. Five different sequence variations were identified in the WISP3 gene, two of them being new mutations: the c.589G -> C transversion at codon 197, responsible for a splicing defect (A197fsX201); and the c.536_537delGT deletion (C179fsX), both in exon 3. In all other families, the affected patients were homozygous for a previously described nonsense mutation, namely c.156C -> A (C52X). Interestingly, in the latter families, the C52X mutation was always found associated with a novel c.248G -> A (G83E) variation, suggesting the existence of a founder effect. (c) 2005 Wiley-Liss.
引用
收藏
页码:118 / 126
页数:9
相关论文
共 21 条
[1]   SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH PROGRESSIVE ARTHROPATHY [J].
ALAWADI, SA ;
FARAG, TI ;
NAGUIB, K ;
ELKHALIFA, MY ;
CUSCHIERI, A ;
HOSNY, G ;
ZAHRAN, M ;
ALANSARI, AG .
JOURNAL OF MEDICAL GENETICS, 1984, 21 (03) :193-196
[2]  
CHAABOUNI H, 1986, Journal de Genetique Humaine, V34, P275
[3]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[4]   Clinical, radiographic, and genetic diagnosis of progressive pseudorheumatoid dysplasia in a patient with severe polyarthropathy [J].
Ehl, S ;
Uhl, M ;
Berner, R ;
Bonafé, L ;
Superti-Furga, A ;
Kirchhoff, A .
RHEUMATOLOGY INTERNATIONAL, 2004, 24 (01) :53-56
[5]  
El-Shanti H, 1997, AM J HUM GENET, V61, pA274
[6]   Progressive pseudorheumatoid dysplasia: Report of a family and review [J].
ElShanti, HE ;
Omari, HZ ;
Qubain, HI .
JOURNAL OF MEDICAL GENETICS, 1997, 34 (07) :559-563
[7]   Genetic linkage of progressive pseudorheumatoid dysplasia to a 3-cM interval of chromosome 6q22 [J].
Fischer, J ;
Urtizberea, JA ;
Pavek, S ;
Vandiedonck, C ;
Bruls, T ;
Saker, S ;
Alkatip, Y ;
Prud'homme, JF ;
Weissenbach, J .
HUMAN GENETICS, 1998, 103 (01) :60-64
[8]   Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia [J].
Hurvitz, JR ;
Suwairi, WM ;
Van Hul, W ;
El-Shanti, H ;
Superti-Furga, A ;
Roudier, J ;
Holderbaum, D ;
Pauli, RM ;
Herd, JK ;
Van Hul, E ;
Rezai-Delui, H ;
Legius, E ;
Le Merrer, M ;
Al-Alami, J ;
Bahabri, SA ;
Warman, ML .
NATURE GENETICS, 1999, 23 (01) :94-98
[9]  
LAPLANE R, 1972, ARCH FR PEDIATR, V29, P831
[10]  
LEGIUS E, 1993, CLIN GENET, V44, P152